Institutions / Barclays PLC / Activity
Activity — Barclays PLC
2,902 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q3 2024 as of | New | 45783Y194 Common stock | $24 | +1 | 1 0.00% of portfolio | low |
| Q1 2023 as of | New | 91532B200 Common stock | $25 | +17 | 17 0.00% of portfolio | low |
| Q4 2024 as of | New | 78464A649 Common stock | $25 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | BEAT HeartBeam, Inc. Common Stock | $26 | +16 | 16 0.00% of portfolio | low |
| Q3 2025 as of | New | IF Bancorp, Inc. Common stock | $26 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | Catalyst Bancorp, Inc. Common stock | $26 | +2 | 2 0.00% of portfolio | low |
| Q3 2024 as of | New | DNA X, Inc. Common stock | $26 | +9 | 9 0.00% of portfolio | low |
| Q3 2024 as of | New | Rezolve Ai PLC Common stock | $27 | +4 | 4 0.00% of portfolio | low |
| Q3 2024 as of | New | SAB Biotherapeutics, Inc. Common stock | $27 | +10 | 10 0.00% of portfolio | low |
| Q3 2025 as of | New | Adagio Medical Holdings, Inc. Common stock | $27 | +14 | 14 0.00% of portfolio | low |
| Q3 2025 as of | New | 17259U204 Common stock | $28 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | Coeptis Therapeutics Holdings Inc Common stock | $28 | +3 | 3 0.00% of portfolio | low |
| Q3 2025 as of | New | VELO Velo3D, Inc. Common Stock | $28 | +9 | 9 0.00% of portfolio | low |
| Q3 2024 as of | New | 45674E109 Common stock | $28 | +102 | 102 0.00% of portfolio | low |
| Q4 2023 as of | New | VHC VirnetX Holding Corp Common Stock | $28 | +4 | 4 0.00% of portfolio | low |
| Q1 2025 as of | New | 02008G201 Common stock | $29 | +9 | 9 0.00% of portfolio | low |
| Q2 2024 as of | New | 28202V207 Common stock | $29 | +100 | 100 0.00% of portfolio | low |
| Q4 2025 as of | New | TWFG, Inc. Common stock | $29 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | 68557F209 Common stock | $29 | +35 | 35 0.00% of portfolio | low |
| Q3 2025 as of | New | 70387R403 Common stock | $29 | +69 | 69 0.00% of portfolio | low |
| Q3 2025 as of | New | LONA LeonaBio, Inc. Common Stock | $29 | +7 | 7 0.00% of portfolio | low |
| Q3 2025 as of | New | ANIX Anixa Biosciences Inc Common Stock | $30 | +9 | 9 0.00% of portfolio | low |
| Q3 2025 as of | New | 754198109 Common stock | $30 | +9 | 9 0.00% of portfolio | low |
| Q3 2024 as of | New | 45783Y848 Common stock | $30 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 78464A474 Common stock | $30 | +1 | 1 0.00% of portfolio | low |
| Q4 2023 as of | New | Dianthus Therapeutics, Inc. Common stock | $31 | +3 | 3 0.00% of portfolio | low |
| Q3 2025 as of | New | 108763103 Common stock | $31 | +4 | 4 0.00% of portfolio | low |
| Q2 2024 as of | New | G5214E103 Common stock | $31 | +14 | 14 0.00% of portfolio | low |
| Q3 2025 as of | New | GNSS Genasys Inc. Common Stock | $32 | +13 | 13 0.00% of portfolio | low |
| Q3 2025 as of | New | PROV Provident Financial Holdings Inc Common Stock | $32 | +2 | 2 0.00% of portfolio | low |
| Q3 2024 as of | New | Beasley Broadcast Group Inc Common stock | $32 | +3 | 3 0.00% of portfolio | low |
| Q1 2023 as of | New | G6096M122 Common stock | $32 | +12 | 12 0.00% of portfolio | low |
| Q3 2025 as of | New | 05343P109 Common stock | $32 | +12 | 12 0.00% of portfolio | low |
| Q1 2024 as of | New | 84465L113 Common stock | $33 | +6K | 5,866 0.00% of portfolio | low |
| Q3 2024 as of | New | NetSol Technologies Inc Common stock | $34 | +12 | 12 0.00% of portfolio | low |
| Q3 2023 as of | New | 28474P201 Common stock | $34 | +55 | 55 0.00% of portfolio | low |
| Q2 2025 as of | New | BOLT Bolt Biotherapeutics, Inc. Common Stock | $35 | +6 | 6 0.00% of portfolio | low |
| Q4 2024 as of | New | IMMP IMMUTEP Ltd ADR | $35 | +16 | 16 0.00% of portfolio | low |
| Q1 2025 as of | New | SHIM Shimmick Corp Common Stock | $36 | +20 | 20 0.00% of portfolio | low |
| Q3 2025 as of | New | PBBK Pb Bankshares Inc Common Stock | $38 | +2 | 2 0.00% of portfolio | low |
| Q3 2025 as of | New | DWTX Dogwood Therapeutics, Inc. Common Stock | $39 | +5 | 5 0.00% of portfolio | low |
| Q4 2023 as of | New | 75629F109 Common stock | $40 | +113 | 113 0.00% of portfolio | low |
| Q3 2025 as of | New | LOOP Loop Industries, Inc. Common Stock | $40 | +27 | 27 0.00% of portfolio | low |
| Q1 2025 as of | New | 30218B209 Common stock | $41 | +43 | 43 0.00% of portfolio | low |
| Q3 2025 as of | New | 901643106 Common stock | $41 | +10 | 10 0.00% of portfolio | low |
| Q4 2025 as of | New | HIMX Himax Technologies, Inc. ADR | $41 | +5 | 5 0.00% of portfolio | low |
| Q1 2025 as of | New | 29405E406 Common stock | $42 | +30 | 30 0.00% of portfolio | low |
| Q2 2025 as of | New | 62956D303 Common stock | $43 | +390 | 390 0.00% of portfolio | low |
| Q1 2025 as of | New | RenovoRx, Inc. Common stock | $43 | +43 | 43 0.00% of portfolio | low |
| Q3 2025 as of | New | 33939J303 Common stock | $43 | +68 | 68 0.00% of portfolio | low |